Cabaletta Bio, Inc. (41) | License Agreements (3)
Recent Contracts
-
Exclusive License Agreement, dated October 7, 2022, by and between the Registrant and Nanjing IASO Biotherapeutics Co., LTD
(Filed With SEC on November 10, 2022)
-
First Amendment, dated May 27, 2020, to the Amended and Restated License Agreement, dated July 23, 2019, among the Company, the Trustees of the University of Pennsylvania and the...
(Filed With SEC on May 28, 2020)
-
Amended and Restated License Agreement, dated as of July 23, 2019, among the Registrant, the Trustees of the University of Pennsylvania and the Childrens Hospital of Philadelphia
(Filed With SEC on September 30, 2019)